Congratulations to @ReneeVickman on the notice of award for a NIH R01 investigating the role of macrophages in #BPH ! 🏆
We need to uncover new disease-modifying targets to help the millions of men with BPH. Exciting times ahead for prostate research! 🧬👏
How can we improve care for men with LUTS and urgency?
1️⃣ Measure symptoms completely and accurately
2️⃣ Identify what matters
3️⃣ Only then can data-driven changes lead to real results. If we don't track it, we can't fix it. 🩺📈 #LUTS#LURN#SOBPD26
Impressive work from Dr @apglaser presenting an overview of his work with LURN. Advancing PROS. UUI men had more DM, higher BMI. need to get better at treating this. Higher levels of central sensitization assoc w OAB 🤯 #SOBPD26
Medicare currently limits #Aquablation for men with bladder stones - a restriction that doesn’t exist for any other BPH procedure. It’s nonsensical and creates an unfair barrier to care. #CMS must change this policy. https://t.co/wQFYqg1fhZ
@RRGonzalezMD@SPuro88 Working on it! 🚀 We’re already 75% recruited for our study of LURN SI-29/10, IPSS, and additional PROs in men with BPH undergoing medical and surgical therapy (NCT05898932). Stay tuned— manuscripts in the works and qualitative interview invites for providers are coming soon!
@SocietyofBPD#SoBPD2025 Faculty & Friends. Congratulations on another year's successful annual meeting. Next up will be the #AUA25 SoBPD program on #Streamteam#bph April 29 2025 - Please join us for
thought-provoking discussions with the experts on the top #BPH science.
Government laws often (always?) come with unintended consequences. The 21st Century Cures Act means patients may learn of their cancer diagnosis via email—before their doctor can explain. But AI offers solutions! Congrats to the team on this work! 🤖👇 https://t.co/w6AxMP0Wju”
Check out our new manuscript describing the inflammatory landscape changes that occur with increasing prostate size and the specific accumulation of lipid-rich macrophages in large BPH tissues!
https://t.co/jJkqaNlpQM
@Dr_KevinZorn (2/2) That being said- I’m excited for the future where integrating and clustering clinical variables, patient-reported outcomes, and genetic markers will push the boundaries of precision medicine!
https://t.co/77p24CCg6h
@Dr_KevinZorn Shocking that race/ethnicity is reported so infrequently.. editors and reviewers need to take note and hold submissions to this basic standard! (1/2)
🎉👏🏼 @EndeavorHlth is thrilled to be ranked as a top hospital for urology!
Our dedication to providing exceptional, innovative, and patient-centered care has been recognized and we couldn't be more excited!
Great to see results from the COURAGE RCT. Vibegron improved all outcome measures for men with #BPH and urgency, with no increased risk of retention or hypertension. Thanks to all the patients who participated in this trial during COVID!
We are more than 1/3 recruited for our BPH Patient Reported Outcome (PRO) study! Love to see enrollment reports like this.. Big thanks to our patients and to our awesome teams at @NorthShoreUro@UChiPritzker and @NorthwesternMed 🙏
NCT05898932
📢Exciting news from the @SocietyofBPD Annual Meeting in Dallas! Emano Flow's advisory board members @apglaser & Dr. Kevin McVary are presenting on BPH outcomes and surgical debates. Don't miss
@Dr_KevinZorn's insights on new tech in the BPH workup.
#urology#bph#HealthTech
Getting closer to understanding and targeting the underlying mechanisms in BPH at @SocietyofBPD annual meeting! How do genetics, metabolic health, and inflammation influence cellular growth in the prostate? @stranddw @prost8helf@LabRicke
5-year data on WATER study published in the Canadian Journal of Urology showing Aquablation therapy yields superior efficacy and safety outcomes for men with prostate sizes of 50-80mL vs. TURP. Dive into the findings in the Canadian Journal of Urology! #HealthInnovation #ProstateHealth
https://t.co/mRonV9nhfp